{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:34:07Z","timestamp":1790858047640,"version":"4.1.0"},"reference-count":28,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2001,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Complement-mediated opsonization of bacteria by C3 binding is an important component of the host innate immune system. Little information is available concerning the interaction between complement proteins and capsule type 5 and 8<jats:italic>Staphylococcus aureus<\/jats:italic>strains, even though these isolates are responsible for \u223c70% of human staphylococcal infections. To investigate the importance of an intact complement pathway in an experimental staphylococcal infection, control and C3-depleted mice were challenged intravenously with 10<jats:sup>7<\/jats:sup>CFU of a serotype 5<jats:italic>S. aureus<\/jats:italic>isolate. Whereas only 8% of the control mice succumbed to the infection, 64% of the complemented-depleted animals died. In vitro parameters of C3 binding to two heavily encapsulated (CP++) strains, three encapsulated (CP+) strains, and an isogenic capsule-negative (CP\u2212) mutant were examined. The alternative pathway contributed 90% of C3 binding in 20% serum at 30 min, whereas it accounted for only 13% of C3 binding in 2% serum. Stationary-phase organisms bound only 10% as much C3 as mid-log-phase organisms; this was only in part due to capsule. When the<jats:italic>S. aureus<\/jats:italic>strains were cultivated on solid medium, the CP++ isolates bound 50% less C3 than CP+ strains; a CP+ strain bound 42% less C3 than the CP\u2212 mutant. Both C3b and iC3b fragments of C3 bound to<jats:italic>S. aureus<\/jats:italic>cells, and about one-third of the bound C3 was shed from the staphylococcal surface as iC3b, regardless of the CP phenotype of the strain. Thus, the phase of growth and presence of capsule are critical to opsonization.<\/jats:p>","DOI":"10.1128\/iai.69.11.6796-6803.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T09:58:18Z","timestamp":1027763898000},"page":"6796-6803","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":106,"title":["Capsule Production and Growth Phase Influence Binding of Complement to<i>Staphylococcus aureus<\/i>"],"prefix":"10.1128","volume":"69","author":[{"given":"K. M.","family":"Cunnion","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710,1and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"Lee","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115-58042"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"Frank","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710,1and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","unstructured":"Ahern J. M. Rosengard A. M. Complement receptors The human complement system in health and disease. Volanakis J. E. Frank M. M. 1998 167 202 Marcel Dekker New York N.Y","DOI":"10.1201\/b14212-9"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.59.3.1008-1014.1991"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/165.4.749"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.39.1.403-409.1983"},{"key":"e_1_3_2_6_2","unstructured":"Centers for Disease Control and Prevention National Nosocomial Infection Surveillance System report: data summary from October 1986\u2013April 1996. U.S. 1996 Department of Health and Human Services Atlanta Ga"},{"key":"e_1_3_2_7_2","first-page":"1165","article-title":"Staphylococcus aureus with reduced susceptibility to vancomycin\u2014Illinois, 1999","volume":"48","author":"Centers for Disease Control and Prevention","year":"2000","unstructured":"Centers for Disease Control and Prevention Staphylococcus aureus with reduced susceptibility to vancomycin\u2014Illinois, 1999.Morb. Mortal. Wkly. Rep.48200011651167","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.13.2.399-406.1976"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(96)80101-4"},{"key":"e_1_3_2_10_2","unstructured":"Frank M. M. The complement system Samter's immunologic diseases. Frank M. M. 1995 331 353 Little Brown and Co. Boston Mass"},{"key":"e_1_3_2_11_2","first-page":"335","article-title":"The role of complement in defense against bacterial disease","volume":"2","author":"Frank M. M.","year":"1998","unstructured":"Frank M. M. Fries L. F. The role of complement in defense against bacterial disease Bailliere's clinical immunology and allergy 2 1998 335 361 Bailliere Tindall Philadelphia, Pa","journal-title":"Bailliere's clinical immunology and allergy"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.4049\/jimmunol.123.3.1195","article-title":"Studies of the molecular mechanisms of C3b inactivation and a simplified assay of \u03b21H and C3b inactivator (C3bINA)","volume":"123","author":"Gaither T. A.","year":"1979","unstructured":"Gaither T. A. Hammer C. H. Frank M. M. Studies of the molecular mechanisms of C3b inactivation and a simplified assay of \u03b21H and C3b inactivator (C3bINA).J. Immunol.123197911951204","journal-title":"J. Immunol."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/157.4.697"},{"key":"e_1_3_2_14_2","first-page":"285","article-title":"Capsular polysaccharides of Staphylococcus aureus","author":"Karakawa W. W.","year":"1982","unstructured":"Karakawa W. W. Vann W. F. Capsular polysaccharides of Staphylococcus aureus Seminars in infectious diseases Robbins J. B. Hill J. C. Sadoff J. C. IV. Bacterial vaccines 1982 285 293 Thieme-Stratton Inc. New York, N.Y","journal-title":"Seminars in infectious diseases"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.5.1853-1858.1993"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.33.3.714-724.1981"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.56.5.1090-1095.1988"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/10408369509084686"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.2.414-420.1998"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.10.4216-4221.1997"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.19.3.943-949.1978"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","unstructured":"Petry F. Loos M. Bacteria and complement The human complement system in health and disease. Volanakis J. E. Frank M. M. 1998 375 392 Marcel Dekker New York N.Y","DOI":"10.1201\/b14212-18"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.9.4865-4871.2000"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.2.917-923.2001"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.22.5.828-834.1985"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.11.5183-5189.1998"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.4049\/jimmunol.129.4.1681","article-title":"Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement","volume":"129","author":"Verbrugh H. A.","year":"1982","unstructured":"Verbrugh H. A. Peterson P. K. Nguyen B.-Y. T. Sisson S. P. Kim Y. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.J. Immunol.129198216811687","journal-title":"J. Immunol."},{"key":"e_1_3_2_28_2","first-page":"191","article-title":"Opsonic requirements for staphylococcal phagocytosis: heterogeneity among strains","volume":"33","author":"Verhoef J.","year":"1977","unstructured":"Verhoef J. Peterson P. K. Kim Y. Sabatu L. D. Quie P. G. Opsonic requirements for staphylococcal phagocytosis: heterogeneity among strains.Immunology331977191197","journal-title":"Immunology"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.4.1358-1362.1992"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.69.11.6796-6803.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.69.11.6796-6803.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T15:03:56Z","timestamp":1682262236000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.69.11.6796-6803.2001"}},"subtitle":[],"editor":[{"given":"V. J.","family":"DiRita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["10.1128\/IAI.69.11.6796-6803.2001"],"URL":"https:\/\/doi.org\/10.1128\/iai.69.11.6796-6803.2001","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11]]},"assertion":[{"value":"2001-03-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-07-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}